UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000817
Receipt number R000000932
Scientific Title Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.
Date of disclosure of the study information 2007/09/05
Last modified on 2016/02/26 17:10:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Acronym

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Scientific Title

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Scientific Title:Acronym

Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Region

Japan


Condition

Condition

Non-small cell lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the efficacy and safety of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Response rate, time to progression, toxicity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

June, 2007-December, 2008
Regimen: TS-1

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Non-small cell lung cancer
2) Stage IIIB or IV
3) Performance status(ECOG) 0-1
4) Prior chemotherapy
5) Adequate haematopoietic function
6) Adequate liver and renal function
7) Each patient signed a written informed consent

Key exclusion criteria

1) Massive pleural effusion
2) Massivepericardial effusion
3) Interstitial pneumonitis
4) Uncontrolled brain metastasis
5) Active infection

Target sample size

32


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeru Kohno

Organization

Nagasaki University School of Medicine

Division name

Second Department of Internal Medicine

Zip code


Address

1-7-1, Sakamoto, Nagasaki, Japan

TEL

095-849-7273

Email

naho-k@mue.biglobe.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Kasai

Organization

Japanese Red Cross Nagasaki Atomic Bomb Hospital

Division name

Internal Medicine

Zip code


Address

3-15 Mori-machi, Nagasaki, Japan

TEL

095-847-1511

Homepage URL


Email

takasai@tochigi-cc.jp


Sponsor or person

Institute

Nagasaki Thoracic Oncology Group

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 09 Month 05 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 06 Month 10 Day

Date of IRB


Anticipated trial start date

2007 Year 06 Month 01 Day

Last follow-up date

2009 Year 12 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 09 Month 04 Day

Last modified on

2016 Year 02 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000932


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name